Nanoparticle-based dmg delivery systems

doi:10.1016/0168-3659(91)90040-K

Journal of Controlled Release

Volume 16, Issues 1–2, June–July 1991, Pages 169-176

https://doi.org/10.1016/0168-3659(91)90040-K Get rights and content

Abstract

Nanoparticles are colloidal polymer particles of a size below 1 μm that are used as carriers for drugs as well as for vaccines. The drugs or antigens may be entrapped in the polymer matrix in particulate form or in the form of a solid solution, or they may be bound to the particle surface by adsorption. In certain cases, the drug also can be bound covalently to the polymer. The drug or antigen may be present during polymerization or may be added to previously produced particles.

A number of preparation methods exist for the manufacture of nanoparticles. These methods include emulsion polymerization, interfacial polymerization, solvent evaporation, and denaturation or desolvation of natural proteins or carbohydrates.

After intravenous injection, nanoparticles like other colloidal drug carriers accumulate in the reticuloendothelial system. This uptake into the reticuloendothelial system can be reduced and the body distribution altered by coating with certain materials such as surfactants. Another way of altering the body distribution is the incorporation of magnetite particles into the nanoparticles and subsequent targeting with a magnetic field.

Other administration routes for nanoparticles include intramuscular or subcutaneous injection, peroral, and ocular administration.

Parenteral administration of a number of cytostatic drugs or antibiotics leads to an enhanced efficacy or reduced toxicity of these drugs, or to both, thus resulting in an improvement of the therapeutic index by binding to nanoparticles.

The binding of vincamine and especially insulin to nanoparticles resulted in an enhancement of the bioavailability after peroral administration.

The elimination rate of nanoparticles from the eye is considerably slower than that of aqueous eye-drop solutions. Probably for this reason, the miosis time and the duration of the intraocular pressure reduction were considerably prolonged after binding of pilocarpine to polycyanoacrylate nanoparticles. The retention ofnanoparticles was greater in inflamed than in normal eyes, indicating a potential for targeting to inflamed tissue.

Poly (methyl methacrylate) nanoparticles are powerful adjuvants for some antigens. These nanoparticles improved the antibody response and the protection against challenge with life virus in comparison to the classical adjuvant aluminium hydroxide using influenza as a model antigen. In addition, the duration of these effects as well as the stability against heat inactivation was improved.

References (63)

T.R. Tice et al.
Preparation of injectable controlled-release microcapsules by a solvent-evaporation process
J. Controlled Rel.
(1985)
J. Kreuter et al.
Distribution and elimination of poly (methyl methacrylate) nanoparticles after subcutaneous administration to rats
J. Pharm. Sci.
(1983)
L. Grislain et al.
Pharmacokinetics and distribution of a biodegradable drug-carrier
Int. J. Pharm.
(1983)
J. Kreuter
Poly(alkyl acrylate) nanoparticles
S.J. Douglas et al.
Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles. I. Influence of physicochemical factors
J. Colloid Interface Sci.
(1984)
S.J. Douglas et al.
Particle size and size distribution of poly(butyl-2-cyanoacrylate) nano-particles. II. Influence of stabilizers
J. Colloid. Interface Sci.
(1985)
P.A. Kramer
Albumin microspheres as vehicles for achieving specificity in drug delivery
J. Pharm. Sci.
(1974)
K. Widder et al.
Magnetic micro-spheres: Synthesis of a novel parenteral drug carrier
J. Pharm. Sci.
(1979)
J.M. Gallo et al.
Analysis of albumin microsphere preparation
Int. J. Pharm.
(1984)
H.G. Schroeder et al.
Distribution of radiolabelled subsieve microspheres after intravenous administration to Beagle dogs
J. Pharm. Sci.
(1978)

L. Illum et al.

The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338)

FEBS Lett.

(1984)

D. Leu et al.

Distribution and elimination of coated poly(methyl-2-¹⁴C-methacrylate) nanoparticles after intravenous injection in rats

J. Pharm. Sci.

(1984)

J. Kreuter et al.

Distribution and elimination of poly(methyl-2-¹⁴C-methacrylate) nanoparticle radioactivity after injection in rats and mice

J. Pharm. Sci.

(1979)

J. Kreuter et al.

Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles

Int. J. Pharm.

(1989)

M. Nefzger et al.

Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats

J. Pharm. Sci.

(1984)

R.W. Wood et al.

Ocular disposition of poly-hexyl-2-cyano[3-¹⁴C]acrylate nanoparticles in the albino rabbit

Int. J. Pharm.

(1985)

R. Diepold et al.

Distribution ofpoly-hexyl-2-cyano[3-¹⁴C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyes

Int. J. Pharm.

(1989)

E.M. Gipps et al.

Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma

J. Pharm. Sci.

(1986)

F. Brasseur et al.

Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: Increased efficiency against an experimental tumor

Eur. J. Cancer

(1980)

P. Couvreur et al.

Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles

J. Pharm. Sci.

(1982)

K.J. Widder et al.

Selective targeting of magnetic albumin microspheres containing low-dose adriamycin: Total remission in Yoshida sarcoma-bearing rats

Eur. J. Cancer Clin. Oncol.

(1983)

K.J. Widder et al.

Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: Ultrastructural evaluation of microsphere disposition

Eur. J. Cancer Clin. Oncol.

(1983)

P. Maincent et al.

Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles

J. Pharm. Sci.

(1986)

T. Harmia et al.

Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles

Int. J. Pharm.

(1986)

J. Kreuter et al.

Influence of the particle size on the adjuvant effect of paniculate polymeric adjuvants

Vaccine

(1986)

J. Kreuter et al.

Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants

Vaccine

(1988)

J. Kreuter

Physicochemical characterization of poly-acrylic nanopariicles

Int. J. Pharm.

(1983)

J. Kreuter

Evaluation of nanoparticles as drug-delivery systems I: Preparation methods

Pharm. Acta Helv.

(1983)

H. Nothdurft

Über die Sarkomauslösung durch Fremdkörperimplantation bei Ratten in Abhängigkeit von der Form der Implantate

Naturwissenschaften

(1955)

H. Nothdurft et al.

Sarkomerzeugung mit Fensterglas

Naturwissenschaften

(1958)

N.E. Stinson

The tissue reaction induced in rats and guinea-pigs by polymethylmethacrylate (acrylic) and stainless steel (18/8/mo)

Br.J. Exp. Pathol.

(1964)

Cited by (232)

Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models
2022, Journal of Controlled Release
Citation Excerpt :
Nanoparticles have received substantial attention over the past few decades as tumor-targeting delivery systems because of their promising tumor-targeting ability compared to small-molecule anticancer drugs and imaging agents [1–3].
Many preclinically tested nanoparticles in existing animal models fail to be directly translated into clinical applications because of their poor resemblance to human cancer. Herein, the enhanced permeation and retention (EPR) effect of glycol chitosan nanoparticles (CNPs) in different tumor microenvironments (TMEs) was compared using different pancreatic tumor models, including pancreatic cancer cell line (BxPC3), patient-derived cancer cell (PDC), and patient-derived xenograft (PDX) models. CNPs were intravenously injected into different tumor models, and their accumulation efficiency was evaluated using non-invasive near-infrared fluorescence (NIRF) imaging. In particular, differences in angiogenic vessel density, collagen matrix, and hyaluronic acid content in tumor tissues of the BxPC3, PDC, and PDX models greatly affected the tumor-targeting efficiency of CNPs. In addition, different PDX models were established using different tumor tissues of patients to predict the clinical EPR effect of CNPs in inter-patient TMEs, wherein the gene expression levels of PECAM1, COL4A1, and HAS1 in human tumor tissues were observed to be closely related to the EPR effect of CNPs in PDX models. The results suggested that the PDX models could mimic inter-patient TMEs with different blood vessel structures and extracellular matrix (ECM) content that critically affect the tumor-targeting ability of CNPs in different pancreatic PDX models. This study provides a better understanding of the heterogeneity and complexity of inter-patient TMEs that can predict the response of various nanoparticles in individual tumors for personalized cancer therapy.
Nanoparticle transport and deposition in a heterogeneous human lung airway tree: An efficient one path model for CFD simulations
2022, European Journal of Pharmaceutical Sciences
Understanding nano-particle inhalation in human lung airways helps targeted drug delivery for treating lung diseases. A wide range of numerical models have been developed to analyse nano-particle transport and deposition (TD) in different parts of airways. However, a precise understanding of nano-particle TD in large-scale airways is still unavailable in the literature. This study developed an efficient one-path numerical model for simulating nano-particle TD in large-scale lung airway models. This first-ever one-path numerical approach simulates airflow and nano-particle TD in generations 0–11 of the human lung, accounting for 93% of the whole airway length. The one-path model enables the simulation of particle TD in many generations of airways with an affordable time. The particle TD of 5 nm, 10 nm and 20 nm particles is simulated at inhalation flow rates for two different physical activities: resting and moderate activity. It is found that particle deposition efficiency of 5 nm particles is 28.94% higher than 20 nm particles because of the higher dispersion capacity. It is further proved that the diffusion mechanism dominates the particle TD in generations 0–11. The deposition efficiency decreases with the increase of generation number irrespective of the flow rate and particle size. The effects of the particle size and flow rate on the escaping rate of each generation are opposite to the corresponding effects on the deposition rate. The quantified deposition and escaping rates at generations 0–11 provide valuable guidelines for drug delivery in human lungs.
Nano drug delivery in intracellular bacterial infection treatments
2022, Biomedicine and Pharmacotherapy
The present work aimed to review the potential mechanisms used by macrophages to kill intracellular bacteria, their entrance to the cell, and mechanisms of escape of cellular immunity and applications of various nanoparticles. Since intracellular bacteria such as Mycobacterium and Brucella can survive in host cells and can resist the lethal power of macrophages, they can cause chronic disease or recur in 10–30% of cases in improved patients Nano drug-based therapeutics are promising tools for treating intracellular bacteria and preventing recurrence of the disease caused by these bacteria. In addition, among their unique features, we can mention the small size and the ability of these compounds to purposefully reach the target location.
Preparation of debranched starch nanoparticles by ionic gelation for encapsulation of epigallocatechin gallate
2020, International Journal of Biological Macromolecules
Starch nanoparticles are promising candidates for the delivery of active compounds or drugs. The purpose of this study was to prepare nanoparticles from debranched starch using an ionic gelation method. Negatively charged carboxymethyl debranched starch (CMDBS) was obtained by modification of debranched starch (DBS). The zeta potential value of CMDBS with a degree of substitution of 0.81 was approximately −26 mV. The starch nanoparticles formed from 2 mg mL⁻¹ CMDBS and cationized DBS (CDBS) had particle sizes of 50 to 100 nm, as determined by transmission electron spectroscopy, and most nanoparticles were spherical in shape. Measurements with a quartz crystal microbalance with dissipation monitoring confirmed a successful adsorption interaction between the negatively charged CMDBS and positively charged CDBS. Epigallocatechin gallate (EGCG) was successfully incorporated into the nanoparticles with the highest encapsulation efficiency of 84.4%, and the resulting nanoparticles showed controlled release of EGCG into simulated gastric and intestinal fluids.
Bio-orthogonal triazolinedione (TAD) crosslinked protein nanocapsules affect protein adsorption and cell interaction
2020, Polymer Chemistry
Albumin-based protein nanocarriers have been widely exploited as drug delivery systems, since they show excellent degradability, low toxicity, but at the same time provide high loading capacity and relevant uptake into cells. For the formation of protein nanocapsules, bio-orthogonal reactions are important so that the material to be encapsulated is not affected by the shell formation. We show that protein nanocapsules with narrow size distributions and low protein adsorption upon contact with blood serum can be synthesized by inverse miniemulsion and interfacial crosslinking of the protein using triazolinediones (TADs) as powerful dienophiles and enophiles, which smoothly perform electrophilic aromatic substitutions and Diels–Alder reactions under ambient conditions. Additionally, we compare the physicochemical and biological properties of TAD-crosslinked protein nanocapsules with conventional diisocyanate crosslinked nanocapsules. We discovered that the type of crosslinker reaction controls the cell uptake of protein nanocapsules towards cancer cells and the interaction with blood proteins since the crosslinkers react with different functional groups within the proteins leading to different surfaces of the protein nanocarriers.
Recent developments in nanoencapsulation of bioactive compounds of microbial sources and their biomedical applications
2020, Recent Developments in Applied Microbiology and Biochemistry: Volume 2
Encapsulation contributes to the protection of the functional properties of bioactive concepts, an improvement in bioavailability, a decrease in instability, and an improvement in chemical and thermal stability. It is achieved by encapsulation, the protection of bioactive concepts from oxygen, light or pH variations, concealment of unpleasant taste/aroma, controlled release, improvement of the solubility of lipophilic compounds in aqueous media, and the absorption of sustained nutrients. Nanoencapsulation is one of the encapsulation techniques that enables the processing of bioactive substances in nanoscale structures, providing protection for bioactive compounds, controlled release from the core, enhanced functionality and food safety, enhancing nutritional value and sensory attributes, and reducing expenses. The efficacy of delivery is affected by particle size and thus has been accomplished in the case of nanoencapsulation, controlled release and targeting of the bioactive compounds as well as better bioavailability than in the case of microencapsulation. In this chapter, we address recent advances in nanoencapsulation of microbial bioactive compounds and their biomedical applications.

View all citing articles on Scopus

View full text

Nanoparticle-based dmg delivery systems

Abstract

J. Controlled Rel.

J. Pharm. Sci.

Int. J. Pharm.

J. Colloid Interface Sci.

J. Colloid. Interface Sci.

J. Pharm. Sci.

J. Pharm. Sci.

Int. J. Pharm.

J. Pharm. Sci.

FEBS Lett.

J. Pharm. Sci.

J. Pharm. Sci.

Int. J. Pharm.

J. Pharm. Sci.

Int. J. Pharm.

Int. J. Pharm.

J. Pharm. Sci.

Eur. J. Cancer

J. Pharm. Sci.

Eur. J. Cancer Clin. Oncol.

Eur. J. Cancer Clin. Oncol.

J. Pharm. Sci.

Int. J. Pharm.

Vaccine

Vaccine

Int. J. Pharm.

Evaluation of nanoparticles as drug-delivery systems I: Preparation methods

Pharm. Acta Helv.

Über die Sarkomauslösung durch Fremdkörperimplantation bei Ratten in Abhängigkeit von der Form der Implantate

Naturwissenschaften

Sarkomerzeugung mit Fensterglas

Naturwissenschaften

The tissue reaction induced in rats and guinea-pigs by polymethylmethacrylate (acrylic) and stainless steel (18/8/mo)

Br.J. Exp. Pathol.